Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.33B 3.89B 496M 443M 413M 375M 706M 48.04B 713M 4.96B 1.94B 24.41B 1.86B 1.82B 78.51B P/E 2026 *
7.32x
P/E 2027 * 6.49x
Enterprise Value 3.33B 3.89B 496M 443M 413M 375M 706M 48.04B 713M 4.96B 1.94B 24.41B 1.86B 1.82B 78.51B EV / Sales 2026 *
0.48x
EV / Sales 2027 * 0.44x
Free-Float
45.7%
Yield 2026 *
6.16%
Yield 2027 * 6.93%
28/08 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
28/08 Tong Ren Tang Technologies Co. Ltd. Enters New E-Commerce Service Cooperation Framework Agreement with Beijing Tong Ren Tang Shuzi Technology Co., Ltd CI
09/07 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
29/06 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
29/06 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
12/06 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
26/05 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
27/04 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
30/03 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
27/03 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
27/03 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
27/03 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
06/02 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
1 day-1.30%
1 week-2.56%
Current month-2.56%
1 month-3.03%
3 months-9.25%
6 months-23.43%
Current year-31.07%
1 week 3
Extreme 3
3.12
1 month 3
Extreme 3
3.24
Current year 2.96
Extreme 2.955
4.56
1 year 2.96
Extreme 2.955
4.95
3 years 2.96
Extreme 2.955
7.03
5 years 2.96
Extreme 2.955
9.28
10 years 2.96
Extreme 2.955
16
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 37 09/07/2026
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.30%-2.56%-36.67%-50.33% 503M
-3.89%-0.75%+34.94%+99.60% 1,060B
-1.92%-2.28%+33.25%+59.43% 623B
-1.91%+2.40%+15.11%+78.51% 480B
-2.19%-2.96%+61.53%+33.55% 352B
-2.03%+1.06%+21.08%+40.60% 345B
-1.92%-0.29%+10.54%+33.58% 274B
-2.36%-1.16%-7.14%+9.54% 249B
-2.89%-1.49%+36.18%+47.75% 223B
-1.39%-1.69%+22.63%+93.19% 182B
Average -2.20%-0.56%+19.14%+44.54% 378.85B
Weighted average by Cap. -2.61%+0.04%+28.30%+64.72%

Financials

2026 *2027 *
Net sales 6.98B 8.17B 1.04B 930M 867M 788M 1.48B 101B 1.5B 10.41B 4.07B 51.24B 3.91B 3.82B 165B 7.56B 8.85B 1.13B 1.01B 940M 853M 1.61B 109B 1.62B 11.28B 4.41B 55.5B 4.23B 4.14B 179B
Net income 454M 532M 67.77M 60.52M 56.46M 51.29M 96.51M 6.56B 97.45M 678M 265M 3.34B 254M 249M 10.73B 514M 601M 76.57M 68.38M 63.79M 57.95M 109M 7.42B 110M 766M 300M 3.77B 287M 281M 12.12B
Net Debt - -
Projected Income Statement - Annual - Tong Ren Tang Technologies Co. Ltd.
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,801
Date Price Change Volume
08/10/26 HKD 3.040 -1.30% 577,000
07/10/26 HKD 3.080 +0.33% 674,000
06/10/26 HKD 3.070 +1.15% 617,000
05/10/26 HKD 3.035 -0.65% 504,000
02/10/26 HKD 3.055 -2.08% 819,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Ratings Surperformance© - Tong Ren Tang Technologies Co. Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.597CNY
Average target price
4.601CNY
Spread / Average Target
+77.16%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Tong Ren Tang Technologies Co. Ltd.
  1. Stock Market
  2. Stocks
  3. 1666 Stock